SHREVEPORT, La., March 20, 2006 (PRIMEZONE) -- Don Harrold (IARD #119079, www.donharrold.net), rates Amgen (Nasdaq:AMGN), Transocean (NYSE:RIG), Texas Instruments (NYSE:TXN), and Johnson & Johnson (NYSE:JNJ).
DonHarrold.net provides unbiased stock ratings from registered investment advisors. DonHarrold.net offers subscription services for Swing traders, Day traders and Penny Stock Traders. DonHarrold.net issues daily market commentary and features a member's area with detailed information on over 12,000 stocks.
Important Stock Rating Changes for Monday, March 20, 2006:
Amgen Inc (Nasdaq:AMGN) -- WEAK BUY
www.donharrold.net/stocks/AMGN.php
Transocean Inc (NYSE:RIG) -- WEAK BUY
www.donharrold.net/stocks/RIG.php
Texas Instruments Inc (NYSE:TXN) -- SELL
www.donharrold.net/stocks/TXN.php
Johnson & Johnson (NYSE:JNJ) -- WEAK BUY
www.donharrold.net/stocks/JNJ.php
Stock Commentary - March 20, 2006
Everything (and I mean everything) seems to be made in China these days. In another commentary, I'll discuss the ramifications of that trade arrangement we seem to have made. You know, the one where we import 90% of our "stuff" from Asian nations while they import 10% from us.
But, that's again, for another commentary.
What's interesting is that the one import we won't want is the Bird Flu. Now, let's be honest, it's a topic that has been left off the lips of most folks for a while. Yet, that import will be the type of thing which will become the focal point of all of us under the wrong circumstances.
Anything even remotely related to an industry whose business it will be to stop the Bird Flu will see a big run the moment you see the first case in the U.S. Amgen (Nasdaq:AMGN) is a big company that may not have much in the pipeline with regard to the Bird Flu's antidote (or they may), but that's not my point.
My point is that sectors move in tandem with the news. The news will soon be more "Bird Flu" and that should affect AMGN with a push higher. At the very least AMGN should outperform the broader markets.
Look, I don't like the idea of profiting at others' expense. But, if you are a trader, AMGN and other biotech companies may provide a safe haven (if I may) for many of us -- regardless of the products they sell.